Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/07/1991 | CA2084184A1 Recombinantly produced lipases for therapeutical treatment |
12/07/1991 | CA2064202A1 Cholesterol esterases with variable substrate specificity |
12/06/1991 | WO1991018979A1 Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof |
12/06/1991 | CA2043951A1 Monoclonal antibody to novel antigen associated with human tumors |
12/06/1991 | CA2042448A1 Antimicrobial peptides and plant disease resistance based thereon |
12/04/1991 | EP0459779A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
12/04/1991 | EP0459747A1 Precursor forms of porcine growth hormone releasing factor and related DNA compounds |
12/04/1991 | EP0459643A2 A recombinant promoter for gene expression in monocotyledonous plants |
12/04/1991 | EP0459630A2 Polypeptides |
12/04/1991 | EP0459577A2 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors |
12/04/1991 | EP0459533A2 Probe groups for the detection of nucleotide variations and genetic polymorphisms |
12/04/1991 | EP0459532A2 Primers and probes for nucleic acid detection |
12/04/1991 | EP0459525A2 Genes encoding a 3-acylation enzyme for macrolide antibiotics |
12/04/1991 | EP0459450A2 Monoclonal antibody recognizing membrane phospholipase A2 and immunoassay of membrane phospholipase A2 |
12/04/1991 | EP0459387A2 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
12/04/1991 | EP0459385A1 Maltopentaose producing amylases |
12/04/1991 | EP0459372A2 Hybridoma and production of biologically active substance |
12/04/1991 | EP0459190A2 Monoclonal anitbodies which bind mevalonate kinase |
12/04/1991 | EP0458971A1 Inosine guanosine kinase |
12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
12/04/1991 | EP0458909A1 Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them |
12/04/1991 | EP0458908A1 Animal model for benign prostatic disease |
12/04/1991 | EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/04/1991 | EP0182888B1 Method and reactant for the differential determination of isoenzymes of the alkaline phosphatase and monoclonal antibody therefore |
12/04/1991 | EP0157852B1 Inviable phages, their production and dna thereof |
12/04/1991 | CN1056713A Anti-oncostatin m monoclonal antibodies |
12/04/1991 | CN1056712A Colone and/or express vectors, process of production and use thereof |
12/03/1991 | US5070192 Genetic engineering, diagnosis of autoimmune diseases |
12/03/1991 | US5070018 Method of controlling gene expression |
12/03/1991 | US5070013 Immunochemical assay for human granulocyte-macrophage colony stimulating factor |
12/03/1991 | US5070009 Process and reagents for the detection of a monocaternary nucleic acid, particularly a rna in a biological material and particularly in leucocyte preparations |
12/03/1991 | US5069901 Deactivated antigens |
12/03/1991 | US5069809 Recombinant deoxynucleic acid |
12/03/1991 | CA1292708C Monoclonal antibody against plasminogen-activating factor |
12/02/1991 | WO1991019000A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS |
12/02/1991 | WO1991018980A1 Compositions and methods for identifying biologically active molecules |
12/02/1991 | CA2084307A1 Compositions and methods for identifying biologically active molecules |
12/02/1991 | CA2083399A1 Monoclonal antibody against the gag protein precursor p55 of human immunodeficiency virus |
12/02/1991 | CA2043620A1 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors |
12/02/1991 | CA2043565A1 Enzyme and dna coding therefor |
12/02/1991 | CA2043535A1 Hybridoma and production of biologically active substance |
12/01/1991 | WO1991018919A1 Purification of human interleukin-4 from a secreted escherichia coli mutant |
11/30/1991 | CA2064710A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
11/30/1991 | CA2043372A1 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
11/30/1991 | CA2043049A1 Precursor forms of procine growth hormone releasing factor and related dna compounds |
11/30/1991 | CA2041415A1 Monoclonal antibodies which bind mevalonate kinase |
11/29/1991 | WO1991018990A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
11/28/1991 | WO1991018293A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
11/28/1991 | WO1991018114A1 Polynucleotide amplification |
11/28/1991 | WO1991018110A1 Method and means to perform biochemical reactions |
11/28/1991 | WO1991018103A1 Method and device for making living cells permeable |
11/28/1991 | WO1991018098A1 Bone and cartilage inductive proteins |
11/28/1991 | WO1991018095A1 High molecular weight dna compositions for use in electrophoresis of large nucleic acids |
11/28/1991 | WO1991018094A1 Particle-mediated transformation of woody plant species |
11/28/1991 | WO1991018093A1 A subpackageable vector for transposable elements |
11/28/1991 | WO1991018092A1 Acid-tolerant salmonella typhi, double aro mutants thereof and use as an oral vaccine for typhoid fever |
11/28/1991 | WO1991018090A1 Novel enzyme preparations and methods for their production |
11/28/1991 | WO1991018088A1 Adeno-associated virus (aav)-based eucaryotic vectors |
11/28/1991 | WO1991018018A1 Improved pseudomonas chimeric protein cytotoxic to human cells bearing il2 receptors |
11/28/1991 | WO1991018015A1 Alveolar surfactant proteins |
11/28/1991 | WO1991018005A1 Cloned genes encoding the d1 dopamine receptor |
11/28/1991 | WO1991018004A1 Antisense inhibitors of the human immunodeficiency virus |
11/28/1991 | WO1991017773A2 New protein-polycation conjugates |
11/28/1991 | WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same |
11/28/1991 | WO1991017755A1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna |
11/28/1991 | WO1991008478A3 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO) |
11/28/1991 | CA2082941A1 Bone and cartilage inductive proteins |
11/28/1991 | CA2082631A1 Antisense inhibitors of the human immunodeficiency virus |
11/28/1991 | CA2064017A1 Particle-mediated transformation of woody plant species |
11/28/1991 | CA2063709A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
11/27/1991 | EP0458673A1 Growth-inhibitory factor and cDNA coding for growth inhibitory factor |
11/27/1991 | EP0458668A1 Papilloma virus probe (HPV66), particularly for the diagnosis of papillomaviral infections in vitro which accompany genital neoplasia, as well as products genetically and immunologically related to this papilloma virus |
11/27/1991 | EP0458437A1 Process for production of human nerve growth factor by genetic engineering |
11/27/1991 | EP0458367A1 Anti-sense regulation of gene expression in plant cells |
11/27/1991 | EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody |
11/27/1991 | EP0458070A1 Cytidine analogue resistance gene DNA and its use |
11/27/1991 | EP0457901A1 Free fatty acid determination. |
11/27/1991 | EP0457898A1 Proteinase inhibitory agents and methods for their use |
11/27/1991 | EP0457856A1 Isolation growth and differentiation of human muscle cells |
11/27/1991 | EP0457852A1 Candida tropicalis transformation system |
11/27/1991 | EP0457766A1 Drosophila receptors homologous to mammalian steroid receptors |
11/27/1991 | EP0425616A4 Use of animal-derived anti-microbial peptides for control of plant pathogens |
11/27/1991 | CN1056427A Gene therapy for cell proliferative diseases |
11/27/1991 | CN1014903B Method for producing interferons |
11/26/1991 | WO1991018997A1 Sequence-specific nonphotoactivated crosslinking agents which bind to the major groove of duplex dna |
11/26/1991 | WO1991018986A1 Marker for yeast strain identification |
11/26/1991 | WO1991018921A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
11/26/1991 | WO1991018618A2 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
11/26/1991 | US5068194 Bacillus stearothermophilus strain having a high protoplast forming ratio |
11/26/1991 | US5068193 Genetic engineering of extrachromosomal elements, plasmids and pyrokarotic microorganisms |
11/26/1991 | US5068192 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence |
11/26/1991 | US5068191 Purified histo-blood group a glycosyltransferase and antibodies thereto |
11/26/1991 | US5068189 Cultures to form DNA vectors |
11/26/1991 | US5068185 Strains of saccharomycetaceae or cryptococcaceae with the chromosomes modified by integration of hybrid genes of galactose regulating protein |
11/26/1991 | CA2083719A1 "sequence-specific non-photoactivated crosslinking agents which bind to the major groove of duplex dna |
11/26/1991 | CA2083694A1 Marker for yeast strain identification |
11/26/1991 | CA2083688A1 Growth factor which inhibits the growth of cells overexpressing the human oncogene erbb-2 |
11/26/1991 | CA2062758A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
11/25/1991 | WO1991018047A2 Mammalian expression of the bmp-2 family |
11/25/1991 | CA2082052A1 Mammalian expression of the bmp-2 family |